Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Spyridon A Mastroyannis"'
Autor:
Gretchen E, Glaser, Olivia D, Lara, Bhavana, Pothuri, Carolina Gomez, Grimaldi, Lauren S, Prescott, Spyridon A, Mastroyannis, Sarah, Kim, Adam C, ElNaggar, Diogo, Torres, Lesley B, Conrad, Michaela, McGree, Amy, Weaver, Warner K, Huh, David E, Cohn, S Diane, Yamada, Amanda N, Fader
Publikováno v:
Gynecologic Oncology. 167:146-151
Patients with gynecologic malignancies may have varied responses to COVID-19 infection. We aimed to describe clinical courses, treatment changes, and short-term clinical outcomes for gynecologic oncology patients with concurrent COVID-19 in the Unite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb0f38193662e80a9094eb271c380a78
https://doi.org/10.1016/j.ygyno.2022.09.017
https://doi.org/10.1016/j.ygyno.2022.09.017
Autor:
Dimitrios Nasioudis, Spyridon A Mastroyannis, Emily M Ko, Ashley F Haggerty, Lori Cory, Robert L Giuntoli, Sarah H Kim, Nawar A Latif
Publikováno v:
International Journal of Gynecologic Cancer. 32:1355-1360
ObjectiveTo investigate the utilization and outcomes of ovarian preservation for premenopausal patients with International Federation of Gynecology and Obstetrics (FIGO) stage I grade 2 and 3 endometrioid endometrial carcinoma undergoing hysterectomy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd9df49507e23f2396101f8dce29cb45
https://doi.org/10.1136/ijgc-2022-003450
https://doi.org/10.1136/ijgc-2022-003450
Publikováno v:
Archives of Gynecology and Obstetrics. 302:481-486
To investigate the epidemiology, clinico-pathological characteristics and outcomes of patients diagnosed with malignant ovarian Sertoli-Leydig cell tumors (SLCTs) in comparison to granulosa cell tumors (GCTs). The National Cancer Institute’s Survei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc963d6c3a68b7bc72f086e250fe6938
https://doi.org/10.1007/s00404-020-05633-z
https://doi.org/10.1007/s00404-020-05633-z
Autor:
Nawar A. Latif, S.H. Kim, Ashley Haggerty, Mark A. Morgan, Spyridon A. Mastroyannis, Emily M. Ko, Robert L. Giuntoli nd, Dimitrios Nasioudis
Publikováno v:
Gynecologic Oncology. 157:634-638
Investigate the prevalence of bilateral salpingo-oophorectomy (BSO) for women ≤50 years with early stage low-grade endometrial stromal sarcoma (LGESS) and its impact on overall survival (OS).Women ≤50 years, diagnosed with stage I LGESS and manag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c83b9266a8efaf6227174051c6f51389
https://doi.org/10.1016/j.ygyno.2020.04.001
https://doi.org/10.1016/j.ygyno.2020.04.001
Autor:
Spyridon A. Mastroyannis, Nawar A. Latif, Dimitrios Nasioudis, Emily M. Ko, Ashley Haggerty, Robert L. Giuntoli, Mark A. Morgan
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 248:63-70
To investigate the safety of uterine preservation in patients with high-grade epithelial ovarian carcinoma (EOC).The Surveillance, Epidemiology, and End Results database was accessed (1988-2014) and patients aged = 45 years, diagnosed with an unilate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f677567eda380e302de21266b6c0009
https://doi.org/10.1016/j.ejogrb.2020.01.039
https://doi.org/10.1016/j.ejogrb.2020.01.039
Publikováno v:
Gynecologic Oncology. 157:89-93
To evaluate trends in the surgical management of young women and pediatric patients with malignant ovarian germ cell tumors (MOGCTs) and associated survival outcomes.Using the Surveillance, Epidemiology, and End Results database we identified patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d866527453104cb084dfc7ee95d41c3
https://doi.org/10.1016/j.ygyno.2020.01.033
https://doi.org/10.1016/j.ygyno.2020.01.033
Autor:
Maureen Byrne, Danielle Mckenna, Ryan Schumacher, Payal Shah, Spyridon Alexandros Mastroyannis, Amy Lodise, Sirithepphavanh Oliver, Lauren Schwartz, Lainie Martin, Susan Domchek, Ashley Haggerty
Publikováno v:
Gynecologic Oncology. 166:S287-S288
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29319c67b46d209419d5fa71590dc875
https://doi.org/10.1016/s0090-8258(22)01813-3
https://doi.org/10.1016/s0090-8258(22)01813-3
Publikováno v:
Gynecologic Oncology. 166:S178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dc175366c6b06ef399ade3983b5875c
https://doi.org/10.1016/s0090-8258(22)01569-4
https://doi.org/10.1016/s0090-8258(22)01569-4
Autor:
Lakeisha Mulugeta-Gordon, Ashley Haggerty, Anna Jo Smith, Spyridon Alexandros Mastroyannis, Sarita Sonalkar, Abike James, Anne Flynn, Emily Ko
Publikováno v:
Gynecologic Oncology. 166:S149
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ecff6a46626a9c50434bdb6bfb506fa
https://doi.org/10.1016/s0090-8258(22)01502-5
https://doi.org/10.1016/s0090-8258(22)01502-5
Autor:
Lara Sissman, Ryan Schumacher, Payal D. Shah, Sirithepphavanh Oliver, Spyridon A. Mastroyannis, Susan M. Domchek, Lainie P. Martin, Amy Lodise, Yilin Dong, Ashley Haggerty, Lauren E. Schwartz, Joseph Hermann
Publikováno v:
Gynecologic Oncology. 162:S30-S31
Objectives: New approvals for upfront maintenance therapy with parp inhibitors in ovarian cancer now indicate a need for germline genetic testing and potentially somatic testing including homologous repair deficiency (HRD) within several months of di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::323ab9f01e7843b2d37b24275353be4a
https://doi.org/10.1016/s0090-8258(21)00702-2
https://doi.org/10.1016/s0090-8258(21)00702-2